← Back to Search

NMDA Receptor Antagonist

OK Group for Pain

Phase 4
Waitlist Available
Led By Sergey Motov, MD
Research Sponsored by Antonios Likourezos
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights

Summary

Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painful syndromes. There is a lack of good options for pain control in such settings.

Eligible Conditions
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Pain Score at 60 Minutes

Trial Design

2Treatment groups
Active Control
Group I: OK GroupActive Control1 Intervention
Drug: Proprietary oral formulation of 0.5mg/kg of ketamine
Group II: AOK GroupActive Control1 Intervention
Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin

Find a Location

Who is running the clinical trial?

Antonios LikourezosLead Sponsor
39 Previous Clinical Trials
8,434 Total Patients Enrolled
17 Trials studying Pain
1,201 Patients Enrolled for Pain
Sergey Motov, MDPrincipal InvestigatorMaimonides Medical Center
17 Previous Clinical Trials
1,535 Total Patients Enrolled
10 Trials studying Pain
885 Patients Enrolled for Pain
Leily Naraghi Bagher Pour, MDPrincipal InvestigatorMaimonides Medical Center
~14 spots leftby Sep 2025